Significance of Cross-Linking of α(2)-Plasmin Inhibitor to Fibrin in Inhibition of Fibrinolysis and in Hemostasis
When blood is clotted, α(2)-plasmin inhibitor (α(2)PI) is cross-linked to fibrin by activated fibrin-stabilizing factor (activated coagulation Factor XIII, plasma transglutaminase). The amount of cross-linked α(2)-PI is proportional to the amount of α(2)PI present at the time of clotting. Plasma fro...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Clin Invest |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society for Clinical Investigation
1982
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371009/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7199538/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110479 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|